Pathogenic Mechanisms of Acute Obstructive Pyelonephritis

Yerzhan Sharapatov; Yermek Turgunov; Alyena Lavrinenko

doi:10.3889/oamjms.2021.5876

Authors

Yerzhan Sharapatov Department of Surgical Diseases, Non-commercial Joint-stock Company, Karaganda Medical University, Karaganda, Kazakhstan https://orcid.org/0000-0001-8124-8582
Yermek Turgunov Department of Surgical Diseases, Non-commercial Joint-stock Company, Karaganda Medical University, Karaganda, Kazakhstan https://orcid.org/0000-0002-6486-3847
Alyena Lavrinenko Collective Use Laboratory, Non-commercial Joint-stock Company, Karaganda Medical University, Karaganda, Kazakhstan https://orcid.org/0000-0001-9436-8778

DOI:

https://doi.org/10.3889/oamjms.2021.5876

Keywords:

Obstructive pyelonephritis, Etiology, Pathogenesis

Abstract

Among urological diseases, the most relevant is infection of the urinary tract. Pyelonephritis is on the 5th place in kidney diseases, and obstructive pyelonephritis occurs in 84% of all pyelonephritis. In the world, among the adult population, 100 people per 100,000 of the population suffer from pyelonephritis. In addition, from year to year, there is an increase in purulent forms of acute pyelonephritis by 4–5 times. This pathology is a separated manifestation of such an important urological problem as complicated urinary tract infection, which accounts for 84–86% of all infections. In acute obstructive pyelonephritis, more severe complications such as bacteriotoxic shock and urosepsis may develop. The mortality rate from these dangerous complications reaches 70–90%. In addition, the number of patients with urosepsis and bacteriotoxic shock has increased 4–6 times in recent years. The review presents current literature data on acute obstructive pyelonephritis. The main causes and pathogenetic mechanisms of the disease development are presented.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

Author Biography

Alyena Lavrinenko, Collective Use Laboratory, Non-commercial Joint-stock Company, Karaganda Medical University, Karaganda, Kazakhstan

research associate of the collective use laboratory of Medical University of Karaganda

References

Hudson C, Mortimore G. The diagnosis and management of a patient with acute pyelonephritis. Br J Nurs. 2020;29(3):144-50. https://doi.org/10.12968/bjon.2020.29.3.144 PMid:32053436 DOI: https://doi.org/10.12968/bjon.2020.29.3.144

Bethel J. Acute pyelonephritis: Risk factors, diagnosis and treatment. Nurs Stand. 2012;27(5):51-6. https://doi.org/10.7748/ns2012.10.27.5.51.c9334 PMid:23256302 DOI: https://doi.org/10.7748/ns2012.10.27.5.51.c9334

Yamamichi F, Shigemura K, Kitagawa K, Fujisawa M. Comparison between non-septic and septic cases in stone related obstructive acute pyelonephritis and risk factors for septic shock: A multi-center retrospective study. J Infect Chemother. 2018;24(11):902-6. https://doi.org/10.1016/j.jiac.2018.08.002 PMid:30174285 DOI: https://doi.org/10.1016/j.jiac.2018.08.002

Czaja CA, Scholes D, Hooton TM, Stamm WE. Population based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis. 2007;45(3):273-80. https://doi.org/10.1086/519268 PMid:17599303 DOI: https://doi.org/10.1086/519268

Lee EH, Kim SH, Shin JH, Park SB, Chi BH, Hwang JH. Effects on renal outcome of concomitant acute pyelonephritis, acute kidney injury and obstruction duration in obstructive uropathy by urolithiasis: A retrospective cohort study. BMJ Open. 2019;9(11):e030438. https://doi.org/10.1136/bmjopen-2019-030438 PMid:31685503 DOI: https://doi.org/10.1136/bmjopen-2019-030438

Colgan R, Williams M, Johnson JR. Diagnosis and treatment of acute pyelonephritis in women. Am Fam Phys. 2011;84(5):519-26. PMid:21888302

Tambo M, Taguchi S, Nakamura Y, Okegawa T, Fukuhara H. Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis. BMC Urol. 2020;20(1):23. https://doi.org/10.1186/s12894-020-00596-4 PMid:32160878 DOI: https://doi.org/10.1186/s12894-020-00596-4

Hamasuna R, Takahashi S, Nagae H, Kubo T, Yamamoto S, Arakawa S, et al. Obstructive pyelonephritis as a result of urolithiasis in Japan: Diagnosis, treatment and prognosis. Int J Urol. 2015;22(3):294-300. https://doi.org/10.1111/iju.12666 PMid:25400222 DOI: https://doi.org/10.1111/iju.12666

Raynor MC, Carson CC. Urinary infections in men. Med Clin. 2011;95(1):43-54. https://doi.org/10.1016/j.mcna.2010.08.015 PMid:21095410 DOI: https://doi.org/10.1016/j.mcna.2010.08.015

Kang CI, Kim J, Park DW, Kim BN, Ha US, Lee SJ, et al. Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections. Infect Chemother. 2018;50(1):67-100. https://doi.org/10.3947/ic.2018.50.1.67 PMid:29637759 DOI: https://doi.org/10.3947/ic.2018.50.1.67

Naboka YL, Gudima IA, Mitusova EV, Bedzhanyan SK, Morgun PP, Kogan MI, et al. Antimicrobial resistance of uropathogens in patients with acute obstructive pyelonephritis(in Russian). Urologiia. 2017;4:27-31. PMid:28952688 DOI: https://doi.org/10.18565/urology.2017.4.27-31

Henry L, Schreiber IV, Conover MS, Chou WC, Hibbing ME, Manson AL, et al. Bacterial virulence phenotypes of Escherichia coli and host susceptibility determines risk for urinary tract infections. Sci Transl Med. 2017;9(382):eaaf1283. https://doi.org/1126/scitranslmed.aaf1283 PMid:28330863 DOI: https://doi.org/10.1126/scitranslmed.aaf1283

Hannan TJ, Mysorekar IU, Hung CS, Isaacson-Schmid ML, Hultgren SJ. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 2010;6(8):e1001042. https://doi.org/10.1371/journal.ppat.1001042 PMid:20811584 DOI: https://doi.org/10.1371/journal.ppat.1001042

Mattoo TK. Vesicoureteral reflux and reflux nephropathy. Adv Chronic Kidney Dis. 2011;18(5):348-54. https://doi.org/10.1053/j.ackd.2011.07.006 PMid:21896376 DOI: https://doi.org/10.1053/j.ackd.2011.07.006

Akilov KA, Beknazarov ZB, Hakkulov EB, Baibekov IM. Scanning electron microscopy of resected ureters in children with ureterohydronephrosis (in Russian). Urologiia. 2014;1:44-7. PMid:24772774

Neves F, Costa WS, Ribeiro JG, Babinski MA, Gallo CB, Sampaio FJ. Structural changes of dilated pelvic ureters in adults. Acta Cirurg Bras. 2014;29(Suppl 3):49-54. https://doi.org/10.1590/s0102-86502014001700010 PMid:25351157 DOI: https://doi.org/10.1590/S0102-86502014001700010

Yarovoy SK, Lavrinova LN, Alexandrov NS, Prokhorov AV. Sensitivity of the main pathogens of infectious and inflammatory diseases of the genitourinary system to the new antibiotic tigecycline(in Russian). Eksp Klin Urol. 2011;4:86-9.

Driyanska VE, Drannik GN, Stepanova NM, Lebed LO, Kruglikov VT, Driyanska VV, et al. Positive effects of modern immunocorrection according to the analysis of cytokines and SPLI in patients with pyelonephritis(in Ukrainian). Lik Sprava. 2014;12:45-56. PMid:26638467

McNally A, Alhashash F, Collins M, Alqasim A, Paszckiewicz K, Weston V, et al. Genomic analysis of extra-intestinal pathogenic Escherichia coli urosepsis. Clin Microbiol Infect. 2013;19(8):E328-34. https://doi.org/10.1111/1469-0691.12202 PMid:23573792 DOI: https://doi.org/10.1111/1469-0691.12202

Grabe M. Guidelines on Urological Infections. Arnhem, Netherlands: European Association of Urology; 2015.

Konoplya AI, Bratchikov OI, Kholimenko IM, Shatokhin MN, Dzharimok AR, Mavrin MY, et al. Condition of the immune status at patients with the serous and purulent pyelonephritis according (in Russian). Urologiia. 2016;2:10-6. PMid:28247654

O’Brien VP, Hannan TJ, Yu L, Livny J, Roberson ED, Schwartz DJ, et al. A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease. Nat Microbiol. 2016;2:16196. https://doi.org/10.1038/nmicrobiol.2016.196 PMid:27798558 DOI: https://doi.org/10.1038/nmicrobiol.2016.196

Sullivan MJ, Ulett GC. Evaluation of hematogenous spread and ascending infection in the pathogenesis of acute pyelonephritis due to group B streptococcus in mice. Microb Pathog. 2020;138:103796. https://doi.org/10.1016/j micpath.2019.103796 PMid:31614193 DOI: https://doi.org/10.1016/j.micpath.2019.103796

Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL. Immune modulation by Group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun. 2012;80(12):4186-94. https:// doi.org/10.1128/IAI.00684-12 PMid:22988014 DOI: https://doi.org/10.1128/IAI.00684-12

Krawczyk B, Sledzinska A, Szemiako K, Samet A, Nowicki B, Kur J. Characterisation of Escherichia coli isolates from theblood of haematological adult patients with bacteraemia: Translocation from gut to blood requires the cooperation ofmultiple virulence factors. Eur J Clin Microbiol Infect Dis. 2015;34(6):1135-43. https://doi.org/10.1007/s10096-015-2331-z PMid:25655758 DOI: https://doi.org/10.1007/s10096-015-2331-z

Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol. 2012;2012:681473. https://doi.org/10.1155/2012/681473 PMid:22506110 DOI: https://doi.org/10.1155/2012/681473

Conover MS, Hadjifrangiskou M, Palermo JJ, Hibbing ME, Dodson KW, Hultgren SJ. Metabolic requirements of Escherichia coli in intracellular bacterial communities during urinary tract infection pathogenesis. mBio. 2016;7(2):e00104-16. https://doi.org/10.1128/mBio.00104-16 PMid:27073089 DOI: https://doi.org/10.1128/mBio.00104-16

Gupta K, Donnola SB, Sadeghi Z, Lu L, Erokwu BO, Kavran M, et al. Intrarenal injection of Escherichia coli in a rat model of pyelonephritis. J Vis Exp. 2017;(125):54649. https://doi.org/10.3791/54649 PMid:28745629 DOI: https://doi.org/10.3791/54649

Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, et al. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: Recent reports. Gut Pathogens. 2019;11:10. https://doi.org/10.1186/s13099-019-0290-0 PMid:30828388 DOI: https://doi.org/10.1186/s13099-019-0290-0

Amanova DE, Lavrinenko AV, Kalieva DK, Matyushko DN, Ivachev PA, Turgunov EM. Comparative evaluation of translocation of GFP-producing Escherichia coli strains in acute intestinal obstruction. Bull Exp Biol Med. 2019;167(5):604-7. https://doi.org/10.1007/s10517-019-04593-y PMid:31625067 DOI: https://doi.org/10.1007/s10517-019-04593-y

Podoprigora GI, Kafarskaya LI, Baynov NA, Shkoporov AN. Bacterial translocation from the intestine: Microbiological, immunological and pathophysiological aspects (in Russian). Bull Russ Acad Med Sci. 2015;6:640-50. https://doi.org/10.15690/vramn564 PMid:27093791 DOI: https://doi.org/10.15690/vramn564

Ramos NL, Saayman ML, Chapman TA, Tucker JR, Smith HV, Faoagali J, et al. Genetic relatedness and virulence gene profiles of Escherichia coli strains isolated from septicaemic and uroseptic patients. Eur J Clin Microbiol Infect Dis. 2010;48(8):2709-14. https://doi.org/10.1007/s10096-009-0809-2 PMid:19763642 DOI: https://doi.org/10.1007/s10096-009-0809-2

Sahl JW, Sistrunk JR, Fraser CM, Hine E, Baby N, Begum Y, et al. Examination of the enterotoxigenic Escherichia coli population structure during human infection. mBio. 2015;6(3):e00501. https://doi.org/10.1128/mBio.00501-15 PMid:26060273 DOI: https://doi.org/10.1128/mBio.00501-15

Johnson JR, Porter S, Johnston B, Kuskowski MA, Spurbeck RR, Mobley HL, et al. Host characteristics and bacterial traits predict experimental virulence for Escherichia coli bloodstream isolates from patients with urosepsis. Open Forum Infect Dis. 2015;2(3):ofv083. https://doi.org/10.1093/ofid/ofv083 PMid:26199950 DOI: https://doi.org/10.1093/ofid/ofv083

Campos-Franco J, Macia C, Huelga E, Diaz-Louzao C, Gude F, Alende R, et al. Acute focal bacterial nephritis in a cohort of hospitalized adult patients with acute pyelonephritis. Assessment of risk factors and a predictive model. Eur J Intern Med. 2017;39:69-74. https://doi.org/10.1016/j.ejim.2016.12.002 PMid:27986362 DOI: https://doi.org/10.1016/j.ejim.2016.12.002

Oka H, Nagamori T, Yamamoto S, Manabe H, Taketazu G, Mukai T, et al. Non-invasive discrimination of acute focal bacterial nephritis with pyelonephritis. Pediatr Int. 2019;61(8):777-80. https://doi.org/10.1111/ped.13910 PMid:31410918 DOI: https://doi.org/10.1111/ped.13910

Owrangi B, Masters N, Kuballa, O’Dea C, Vollmerhausen TL, Katouli M. Invasion and translocation of uropathogenic Escherichia coli isolated from urosepsis and patients with community-acquired urinary tract infection. Eur J Clin Microbiol Infect Dis. 2017;37(5):833-9. https://doi.org/10.1007/s10096-017-3176-4 PMid:29340897 DOI: https://doi.org/10.1007/s10096-017-3176-4

Mugazov M, Turgunov Y, Kaliyeva D, Matyushko D, Koishibayev Z, Omertayeva D, et al. The role of presepsin in patients with acute surgical diseases. Open Access Maced J Med Sci. 2019;7(8):1282-6. https://doi.org/10.3889/oamjms.2019.292 PMid:31110570 DOI: https://doi.org/10.3889/oamjms.2019.292

Dammeyer T, Tinnefeld P. Engineered fluorescent proteins illuminate the bacterial periplasm. Comput Struct Biotechnol J. 2012;3:e201210013. https://doi.org/10.5936/csbj.201210013 PMid:24688673 DOI: https://doi.org/10.5936/csbj.201210013